一个新的护理导航干预,用于患有甲基胺使用障碍的患者
Scott A Simpson1,2, Chris Newton3, Alia Al-Tayyib4,5
1Department of Behavioral Health Services, Denver Health and Hospital Authority, Denver, CO, United States. scott.simpson@cuanschutz.edu.
Community mental health journal
|December 11, 2025
概括
一项新的护理导航干预措施成功使64%的甲基胺使用障碍 (MaUD) 患者参与治疗. 这种方法解决了社会和财务障碍,为成恢复提供了实际支持.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 患有甲基胺使用障碍 (MaUD) 的患者遇到基于证据的成治疗的重大障碍.
- 现有的关联护理模式,主要是针对传染病,可以适应物质使用障碍.
研究的目的:
- 开发和评估一个护理导航干预对患有MAUD的患者后急性护理.
- 通过解决患者特定障碍,改善对成治疗的参与度.
主要方法:
- 一项随机对照试验被用来测试护理导航干预措施.
- 干预措施包括建立关系,创伤信息化护理,实践援助和应急管理.
- 评估了患者的特征,护理需求和参与结果.
主要成果:
- 在接受干预的94名患者中,有64%的患者至少进行了两次导航访问.
- 常见的障碍包括不稳定的住房 (85%),失业 (83%) 和缺乏电话接入 (46%).
- 主要需求是获得成治疗,住房和沟通支持.
结论:
- 护理导航是一个可行的模式,可以将MAUD患者与急性护理后的成治疗联系起来.
- 解决实际障碍对于这一群体的治疗参与至关重要.
- 该干预表明,有潜力改善对物质使用障碍的护理连续性.
相关概念视频
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
780
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
780
01:30Community Based Intervention
255
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
255
01:30Specialized Care Centers and Settings-II
1.2K
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.2K
01:28Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
646
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
646